Lavie Bio Ltd.

www.lavie-bio.com

Formerly Plantero, Phanteome

High-Tech Company

Acquired by ICL

TECH VERTICALS

AgriBiotech, AgriTech, Artificial Intelligence, Big Data, Biologicals, Biopesticides, Biostimulants, FoodTech

General Data

Sector	Agritech
Company Stage:	Initial Revenues
Established	2019
Number of Employees	45
Employees in Israel	20
Reg. Number:	abCDe

DESCRIPTION

Lavie Bio aims to improve food quality, sustainability and agriculture productivity through the introduction of microbiome-based ag-biological products. The company utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene’s proprietary MicroBoost AI tech-engine, harnessing the power of big data, artificial intelligence and advanced informatics, for the discovery, optimization and development of bio-stimulant and bio-pesticide products.

TECHNOLOGY

Lavie Bio’s BDD (Biological Driven Design) platform incorporates big data, advanced AI capabilities and a proprietary microbial collection. MicroFermentor is based on an innovative microbe formulation that enables the multiplication of beneficial bacteria directly on the plant, reducing application costs, extending shelf life and prolonging the bacteria's viability after field application.

	TARGET MARKETS
	Seed and chemicals ag-companies, ag-distributors and retail, fresh produce companies, farmers.

	BUSINESS MODEL
	B2B2C

COMPETITORS

Certis Bio , Bioceres , Biotalys , Aphea.bio

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
CA4752FC-1F7A-E111-AC59-00155D32A403		Compugen Ltd.
28C967EA-1F7A-E111-AC59-00155D32A403	Spin-off	Keddem Bioscience Ltd.	Compugen Ltd.	Ceased
6FC86FE4-1F7A-E111-AC59-00155D32A403	Spin-off	Evogene Ltd.	Compugen Ltd.
C9188384-59BF-E111-B9B4-00155D32A408	Spin-off	Neviah Genomics Ltd.	Compugen Ltd.	Ceased
946E1138-207A-E111-AC59-00155D32A403	Spin-off	Casterra AG Ltd.	Evogene Ltd.
BEFD8DDA-9AEC-E811-80F9-0050569A1018	Spin-off	AgPlenus Ltd.	Evogene Ltd.
39BE7B95-9448-E911-80FE-0050569A1018	Subsidiary	Lavie Bio Ltd.	Evogene Ltd.	Acquired/Merged
3B5B066D-7BBD-E711-80D7-00155D0B832C	Subsidiary	Biomica Ltd.	Evogene Ltd.
79A26E96-A056-E911-80FE-0050569A1018	Subsidiary	Canonic Ltd.	Evogene Ltd.	Ceased

REMARKS

Date	Remark
21/04/2025	Evogene announced the acquisition of most of the activity of Lavie Bio by Dead Sea Works Ltd. (an affiliate of ICL Group), or ICL, for an aggregate consideration of $15.25m. In addition, ICL will acquire Evogene’s MicroBoost AI Tech-Engine for the agriculture field for approximately $3.5m. As part of the transaction Lavie Bio will redeem the SAFE which was made by an ICL affiliate in Aug 2022.
28/02/2024	Lavie Bio Ltd. announced that it has successfully secured the second-half advance payment of $2.5 million after meeting Corteva's (NYSE: CTVA) licensing agreement requirements. This payment signifies the completion of a $5 million advance payment outlined in the licensing agreement signed in July 2023. Following the initial $2.5 million installment received in September 2023, Lavie Bio has now fulfilled the requirements set by Corteva and secured the remaining portion of the advance payment.
20/02/2024	Syngenta and Lavie Bio announce partnership to discover and develop novel bio-insecticide.
23/07/2023	Lavie Bio announces successful launch of its first product - bio-inoculant Thrivus, a yield-increasing seed treatment for spring wheat. During the 2022 season, Lavie Bio sold via Ag-retailers to farmers in North Dakota and plans to further expand sales in North America.
18/07/2023	Lavie Bio signed a license agreement for biological fungicides with the American agro-chemical company Corteva agrisciences. According to the agreement, Corteva will receive exclusive rights to the first biofungicide developed by Lavie Bio and intended for protection against fruit rot and powdery mildew in vineyards, fruits and vegegtables.

CONTACT INFO

Expand / Collapse All

Main Address: Rehovot, Israel

Address	13 Gad Feinstein, Park Rehovot
POB	2100
City	Rehovot
Country	Israel
Zip	7638517

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: St. Louis, United States

Address	3730 Foundry Way, Suite 218
City	St. Louis
State/Province	MO
Country	United States
Zip	63110

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Amit Noam	CEO	Acclym (COO)
Dr. Hagai Karchi	Founder	Compugen (Co-Head, Plant Genomics Division)

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Jul. 08, 2025

Initial Revenues

abCDe

Acquired Lavie Bio’s proprietary Biology Driven Design (BDD) technology platform. Concurrently, Evogene has sold its MicroBoost AI Tech-Engine for Agriculture, a computational engine designed to optimize microbial discovery and development through artificial intelligence, for an additional consideration of $3.5m.

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Traditional Industry	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

First Round

Aug. 17, 2022

Initial Revenues

abCDe

Seed

Nov. 13, 2019

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Traditional Industry	abCDe	in addition to the $10m, Corteva transferred all shares of its wholly owned subsidiary Taxon Biosciences. It holds 30% of the company.

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Sep. 30, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2021

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe